semaglutide and sickness Ozempic (Semaglutide): GLP-1 receptor agonist used for type 2 diabetes. It commonly causes dose-related gastrointestinal side-effects, while important serious warnings include pancreatitis, gallbladder disease, dehydration-related acute kidney injury NW Integrative Medicine: Semaglutide Treatment

The authors concluded that approximately 90% of post-operative CL cases could be effectively treated using their MCT diet/EN management strategy, surpassing success rate higher than that reported in numerous studies

[Google Scholar] Tseng LM, Yin PH, Chi CW, Hsu CY, Wu CW et al

Typically, gastrointestinal (GI) side effects of GLP-1s, such as nausea and vomiting, are dose-dependent, mild-to-moderate in severity and occur mostly during initiation of therapy and up-titration

One document warns that a peptide, MOTS-c, marketed online to promote the metabolism of fatty acids in the liver, insulin resistance and weight loss, hasn't been proven safe for human use in compounded drugs

High-dose oral supplementation may be another treatment option, because consuming 1,000 g (1 mg) per day of vitamin B 12 orally should result in the absorption of about 10 g/day (1% of dose) by passive diffusion

Animal reproductive studies show no teratogenic effects at therapeutic doses, but controlled human pregnancy data is limited